Nautilus Biotechnology annual ebitda
2020
2022
2023
2024
2025
Nautilus Biotechnology EBITDA Growth & History (NAUT)
Nautilus Biotechnology's calculated EBITDA was −$60.4M for fiscal 2025.
View full Nautilus Biotechnology company overviewNautilus Biotechnology annual ebitda history
| Fiscal year | Period ended | EBITDA | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$60.4M | $14.7M | — |
| 2024 | 2024-12-31 | −$75.0M | −$4.6M | — |
| 2023 | 2023-12-31 | −$70.4M | −$10.2M | — |
| 2022 | 2022-12-31 | −$60.2M | — | — |
| 2020 | 2020-12-31 | $133,965 | — | — |
Nautilus Biotechnology quarterly ebitda
Q3.20
Q1.21
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | EBITDA | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$14.5M | $985,000 | — |
| Q1 2026 | 2026-03-31 | −$14.6M | — | — |
| Q4 2025 | 2025-12-31 | −$13.8M | — | — |
| Q3 2025 | 2025-09-30 | −$13.9M | — | — |
| Q2 2025 | 2025-06-30 | −$15.5M | — | — |
| Q1 2021 | 2021-03-31 | −$1.6M | — | — |
| Q3 2020 | 2020-09-30 | $25,329 | — | — |
Nautilus Biotechnology ebitda trends
Over the last five fiscal years, Nautilus Biotechnology's ebitda decreased from $133,965 to −$60.4M, a change of −$60.5M. The latest reported quarter, Q2 2026, shows −$14.5M.
About the metric
What EBITDA means
EBITDA is a measure of operating performance before interest, taxes, depreciation, and amortization. It can help compare operating results, but it is not a substitute for cash flow or GAAP net income.
Calculation and source
How TickerStat calculates EBITDA
TickerStat calculates EBITDA as operating income plus reported depreciation and amortization for aligned fiscal periods. It is calculated data, not adjusted EBITDA or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Nautilus Biotechnology source filings ↗